Table 4 Characteristics of the overall survival of patients in the included studies
Surname(Year) | Country | Cancer type | Survival analysis | HR statistic | Hazard ratios | Lower 95% CI | Higher 95% CI | Follow-up months | Outcome |
|---|---|---|---|---|---|---|---|---|---|
TL Zheng(2018 September) | China | non-small cell lung cancer | Univariate | survival curves | 6.00 | 0.52 | 69.08 | 60 | OS |
DL Wang(2020 July) | China | non-small cell lung cancer | Univariate/Multivariate analysis | data in paper | 3.37 | 1.43 | 4.78 | 60 | OS |
J Liu(2017 May) | China | glioblastoma | Univariate | survival curves | 1.99 | 0.74 | 4.62 | 60 | OS |
C Yang(2017 October) | China | osteosarcoma | Univariate | survival curves | 2.66 | 0.78 | 9.07 | 50 | OS |
JJ Yan(2018 November) | China | gastric cancer | Univariate | survival curves | 10.77 | 0.26 | 11.84 | 100 | OS |
S Xue(2015 April) | China | clear cell renal cell carcinoma | Univariate/Multivariate analysis | data in paper | 4.19 | 1.45 | 11.21 | 60 | OS |
PN Hu(2015 August) | China | breast cancer | Univariate | survival curves | 4.18 | 2.64 | 6.62 | 60 | OS |
CS Yan(2017 April) | China | ovarian cancer | Univariate | survival curves | 4.57 | 0.41 | 50.40 | 60 | OS |
L Wei(2021 January) | China | hepatocellular carcinoma | Univariate | survival curves | 1.23 | 0.32 | 4.76 | 60 | OS |
Gaurav Kumar Pandey(2014 November) | Sweden | neuroblastoma | Univariate | survival curves | 4.78 | 0.81 | 28.34 | 300 | OS |
Dan Du(2017 June) | China | bladder cancer | Univariate | survival curves | 1.48 | 0.37 | 5.88 | 60 | OS |